PAMAfrica

Portfolio approach to developing the next-generation of malaria treatments for Africa

Speakers

1

Dr Tim Wells

Chief Scientific Officer, MMV

Dr Juvenal Armando

Administrative Director, Manhiça Foundation (CISM)

Ms Joy Phumaphi

Executive Secretary of the African Leaders Malaria Alliance (ALMA)

Dr Pedro Alonso

Director WHO-GMP

Dr Michael Makanga

EDCTP Executive Director

Dr Sujata Vaidyanathan

Development Unit Head, Global Health at Novartis

Mr Pierre Hugo

MBA, Senior Director Access and Product Management, MMV

Mr Palu Dhanani

Managing Director of Universal Corporation

Dr Jutta  Reinhard-Rupp

Head Global Health Institute, Merck

Ms Zoleka Ngcete

Program Manager at South African Medical Research Council 

Dr Wiweka Kaszubska

Vice President, Head of Product Development, MMV

Dr Ghyslain Mombo-Ngoma

Head of Clinical Operations at CERMEL

Dr Sabine Pfeffer

Senior Global Program Team Director, Novartis

Dr Bérenger Kaboré

Research Associate, Nanoro HDSS, Burkina Faso

Dr Helen Demarest

Director, Clinical Operations, MMV

Dr Eusebio Macete

General Director of Empresa Farmácias de Moçambique, SA

Dr Núria Casamitjana Badia

Director of Training and Education, ISGlobal

Ms Olaug Bergseth

Associate Director, External Relations, MMV

Dr Montserrat Blázquez

Senior Project Officer, EDCTP